FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Hosseini, R. [1 ]
Brown, L. [1 ]
Rodriguez-Monguio, R. [2 ]
Seoane-Vazquez, E. [1 ]
机构：
[1] Chapman Univ, Sch Pharm, Irvine, CA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH101
引用
收藏
页码：S453 / S453
页数：1
相关论文
共 50 条
  • [41] Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy
    Convertino, Irma
    Cazzato, Massimiliano
    Tillati, Silvia
    Giometto, Sabrina
    Gini, Rosa
    Valdiserra, Giulia
    Cappello, Emiliano
    Ferraro, Sara
    Bonaso, Marco
    Bartolini, Claudia
    Paoletti, Olga
    Lorenzoni, Valentina
    Trieste, Leopoldo
    Filippi, Matteo
    Turchetti, Giuseppe
    Cristofano, Michele
    Blandizzi, Corrado
    Mosca, Marta
    Lucenteforte, Ersilia
    Tuccori, Marco
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] Drug retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in Korean patients with seropositive rheumatoid arthritis
    Lee, Bong -Woo
    Lee, Jennifer Jooha
    Kim, Wan-Uk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (05): : 833 - +
  • [43] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD) IN THE TREATMENT OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    HALBERG, P
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, : 55 - 57
  • [44] Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions
    Abasolo, Lydia
    Leon, Leticia
    Rodriguez-Rodriguez, Luis
    Tobias, Aurelio
    Rosales, Zulema
    Leal, Jose Maria
    Castano, Victor
    Vadillo, Cristina
    Macarron, Pilar
    Fontsere, Oscar
    Jover, Juan Angel
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (05) : 506 - 513
  • [45] The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Otani, Hiroshi
    Abe, Asami
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    INTERNAL MEDICINE, 2023, 62 (03) : 373 - 379
  • [46] Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients
    Xie, Fenglong
    Yun, Huifeng
    Levitan, Emily B.
    Muntner, Paul
    Curtis, Jeffrey R.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (08) : 1004 - 1018
  • [47] Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic Drugs
    Ozen, Gulsen
    Pedro, Sofia
    England, Bryant R.
    Mehta, Bella
    Wolfe, Frederick
    Michaud, Kaleb
    ACR OPEN RHEUMATOLOGY, 2019, 1 (07) : 424 - 432
  • [48] Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study
    Freitas, Raquel
    Godinho, Fatima
    Madeira, Nathalie
    Fernandes, Bruno Miguel
    Costa, Flavio
    Santiago, Mariana
    Neto, Agna
    Azevedo, Soraia
    Couto, Maura
    Sequeira, Graca
    Dias, Joao Madruga
    Bernardes, Miguel
    Miranda, Luis
    Pereira, Joaquim Polido
    Fonseca, Joao Eurico
    Santos, Maria Jose
    DRUGS & AGING, 2020, 37 (12) : 899 - 907
  • [49] Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study
    Raquel Freitas
    Fátima Godinho
    Nathalie Madeira
    Bruno Miguel Fernandes
    Flávio Costa
    Mariana Santiago
    Agna Neto
    Soraia Azevedo
    Maura Couto
    Graça Sequeira
    João Madruga Dias
    Miguel Bernardes
    Luís Miranda
    Joaquim Polido Pereira
    João Eurico Fonseca
    Maria José Santos
    Drugs & Aging, 2020, 37 : 899 - 907
  • [50] HOW EFFECTIVE AND SAFE ARE BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN ELDERLY AND VERY ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS?
    Freitas, R.
    Madeira, N.
    Fernandes, B. M.
    Costa, F.
    Santiago, M.
    Neto, A.
    Azevedo, S.
    Madruga Dias, J.
    Couto, M.
    Bernardes, M.
    Cunha Miranda, L.
    Polido-Pereira, J.
    Fonseca, J. E.
    Santos, M. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 294 - 295
12345